Back to funds
View filing
Remedium Capital Partners, LLC
hedge fundUpdated 34 days agoManaged by Remedium Capital Partners, Llc • Latest filing Q2 2026
Portfolio value
$451.6M
Q2 2026
Filings
3
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 3 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $170.2M |
| Q1 2026 | $319.8M |
| Q2 2026 | $451.6M |
Top holdings
6 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | O ORKA Oruka Therapeutics Inc | $149M | 1.57M | 32.99% | — |
| 2 | S SYRE Spyre Therapeutics Inc | $130M | 1.46M | 28.78% | — |
| 3 | A APGE Apogee Therapeutics Inc | $77.9M | 586.7K | 17.24% | — |
| 4 | ? N/A Damora Therapeutics Inc | $53.2M | 2.05M | 11.78% | — |
| 5 | J JBIO Jade Biosciences Inc | $35.1M | 1.58M | 7.76% | — |
| 6 | ? N/A Crescent Biopharma Inc | $6.5M | 361.3K | 1.44% | — |